Fazax is a global biopharmaceutical company founded in 2010. Today, Fazax is one of the world's leading developers of innovative healthcare solutions. Leveraging the scientific potential and expertise of its own research centers in the US and Europe, as well as a global network of partnerships with independent institutes and scientists, the company is advancing two strategic areas of research and development. The Fazax Future Science division focuses on the mRNA platform for applications in immunology, oncology, and virology. The Fazax Health Solutions division operates in therapeutic areas such as dermatology, trichology, neurology, endocrinology, dentistry, and toxicology, including health support and specialized care products.